DJIA 17,689.86 -56.12 -0.32%
NASDAQ 5,128.28 -0.50 -0.01%
S&P 500 2,103.84 -4.79 -0.23%
market minute promo

ImmunoGen (NASDAQ: IMGN)



company name or ticker

1 Small-Cap Biotech Stock to Buy and Hold For the Next 10 Years

Small cap biotech stocks have a lot of inherent risk, but if you can snag a winner your returns could double many times over. Here's one small-cap biotech stock you can consider buying and holding for the next 10 years.

5 Promising Biotech Stocks Under $10

Don't let their share price fool you. These five biotech stocks have the potential to double your money many times over if their product pipelines meet expectations.

Bind Therapeutics Inc, Noble Energy, Inc., Others Are Moving After-Hours

ImmunoGen (IMGN) in Focus: Stock Rises 5.1% in Session - Tale of the Tape

Stock To Watch: Immunogen (IMGN) In Perilous Reversal

Canaccord Hot And Cold On Deals By Teva Pharmaceutical, ImmunoGen

Immunogen (IMGN) Stock Gains Today After Selling Kadcyla Royalty Rights for $200 Million

Why ImmunoGen Inc. is Skyrocketing Today

ImmunoGen Inc. has sold royalty rights in Kadcyla to TPG Special Situations Partners.

Immunogen (IMGN) Strong On High Relative Volume Today

ImmunoGen: Investors Shouldn't Read Too Much Into The Takeda Deal

See More Articles...